- You can view the full Novartis Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.
Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.
House Democrats start probe into MS drug prices
Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.
Dirk Van de Put of McCain Foods is the snack company's new CEO, starting in November.